Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-05-24
2011-05-24
Ward, Paul V. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S912000, C540S145000
Reexamination Certificate
active
07947729
ABSTRACT:
A compound having preferential localization in tumor tissue relative to normal tissue, a preferential electromagnetic absorption at a wavelength between about 660 and 900 nm, and a fluorescence at a wavelength shifted from the preferential absorption by at least +30 nm and preferably at least +50 nm. The compound further preferably destroys tumor tissue in which it is absorbed when exposed to light at its preferential absorption wavelength. In a preferred embodiment of the invention, the compound is a conjugate of a tumor avid tetrapyrrole compound with a fluorescent dye, and more preferably the fluorescent dye is an indocyanine dye such as indocyanine green. The tumor avid tetrapyrrole compound is preferably a porphyrin derivative selected from the group consisting of chlorins, bacteriochlorins, purpurins and derivatives thereof.
REFERENCES:
patent: 4649151 (1987-03-01), Doughertv
patent: 4866168 (1989-09-01), Doughertv
patent: 4889129 (1989-12-01), Doughertv
patent: 4932934 (1990-06-01), Doughertv
patent: 4968715 (1990-11-01), Doughertv
patent: 5002962 (1991-03-01), Pandev
patent: 5015463 (1991-05-01), Doughertv
patent: 5028621 (1991-07-01), Doughertv
patent: 5145863 (1992-09-01), Doughertv
patent: 5198460 (1993-03-01), Pandev
patent: 5225433 (1993-07-01), Doughertv
patent: 5314905 (1994-05-01), Pandev
patent: 5459159 (1995-10-01), Pandev
patent: 5498710 (1996-03-01), Pandev
patent: 5591847 (1997-01-01), Pandev
patent: 5707986 (1998-01-01), Miller et al.
patent: 6103751 (2000-08-01), Pandev
Pinedo et al., “Translational Research . . . ”, The Oncologist 2000,, 5 (suppl1): 1-2 (www.The Oncologist .com).
McMahon, Gerald, “VEGF Receptor Signaling in Tumor Angiogenesis”, The Oncologist 2000; 5(suppl 1): 3-10 (www.The Oncologist.com).
“Use of the Chlorophyll Derivative Purpurin-18, for Synthesis of Sensitizers for Use in Photodynamic Therapy”, Lee et al., J.Chem.Soc., 1993, (19) 2369-77.
“New Synthesis of Benzoporphyrin Derivatives and Analogues for Use in Photodynamic Therapy”, Meunier et al., Bioorganic & Midicinal Chemistry Letters, vol. 2, No. 12, pp. 1575-1580, 1992.
“Photosensitizing Properties of Bacteriochlorophyllin a and Bacteriochlorin a, Two Derivatives of Bacteriochlorophyll a”, Beems et al., Photochemistry and Photobiology, 1987, v. 46, 639-643.
“Photoradiation Therapy. II. Cure of Animal Tumors With Hematoporphyrin and Light”, Dougherty et al., Journal of the National Cancer Institute, Jul. 1975, v. 55, 115-119.
“Photodynamic therapy of C3H mouse mammary carcinoma with hematoporphyrin di-esters as sensitizers”, Evensen et al., Br. J. Cancer, 1987, 55, 483-486.
“Substituent Effects in Tetrapyrrole Subunit Reactivity and Pinacol-Pinacolone Rearrangements: VIC-Dihydroxychlorins and VIC-Dihydroxybacteriochlorins” Pandey et al., Tetrahedron Letters, 1992, v. 33, 7815-7818.
“Photodynamic Sensitizers from Chlorophyll: Purpurin-18 and Chlorin p6”, Hoober et al., 1988, v.48, 579-582.
“Structure/Activity Relationships Among Photosensitizers Related to Pheophorbides and Bacteriopheophorbides”, Pandey et al., Bioorganic and Medicinal Chemistry Letters, 1992, v 2, 491-496.
“Chemistry of Photofrin II and Some New Photosensitizers”, Pandey et al., Photodynamic Therapy: Mechanisms (1989) (SPIE), vol. 1065, pp. 164-174.
“Fast Atom Bombardment Mass Spectral Analyses of Photofrin II and its Synthetic Analogs”, Pandey et al., Biomedical and Environmental Mass Spectrometry, 1990, v. 19, 405-414.
“Indocyanine Green as A Prospective Sensitizer for Photodynamic Therapy of Melanomas”, Krystyna et al., Acta Biochimica Polonica, 2002, v. 49, No. 2/2002, 387-391 Quarterly.
“Hydrophilic Cyanine Dyes as Contrast Agents for Near-Infrared Tumor Imaging; Synthesis, Photophysical Properties and Spectroscopic in vivo Characterization”, Licha et al., BioOne, 2000, vol. 72, Issue 3, pp. 392-398.
“Ultraviolet Spectrum/Light The Cause of Color”; 7th Grade Science, Chasteen T.G., Sam Houston State University, Dept. of Chemistry; Jun. 12, 2003 from www.shsu.edu/%7Echm—tcg/sounds/sound.html (instrumentation video clips).
Chen Yihui
Oseroff Allan
Pandey Ravindra K.
Potter William
Dunn Michael L.
Health Research , Inc.
Ward Paul V.
LandOfFree
Adduct of fluorescent dye and tumor avid tetrapyrrole does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adduct of fluorescent dye and tumor avid tetrapyrrole, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adduct of fluorescent dye and tumor avid tetrapyrrole will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2666891